Lee Seung Hyo, Hong Won Pyo, Kim Joonghee, Cho Youngjin, Lee Eunkyoung
National Fire Agency Pre-hospital Emergency Medical Research TF, Sejong, Korea.
National Emergency Medical Center, National Medical Center, Seoul, Korea.
Yonsei Med J. 2024 Mar;65(3):174-180. doi: 10.3349/ymj.2023.0341.
Prehospital telecardiology facilitates early ST-elevation myocardial infarction (STEMI) detection, yet its widespread implementation remains challenging. Extracting digital STEMI biomarkers from printed electrocardiograms (ECGs) using phone cameras could offer an affordable and scalable solution. This study assessed the feasibility of this approach with real-world prehospital ECGs.
Patients suspected of having STEMI by emergency medical technicians (EMTs) were identified from a policy research dataset. A deep learning-based ECG analyzer (QCG™ analyzer) extracted a STEMI biomarker (qSTEMI) from prehospital ECGs. The biomarker was compared to a group of human experts, including five emergency medical service directors (board-certified emergency physicians) and three interventional cardiologists based on their consensus score (number of participants answering "yes" for STEMI). Non-inferiority of the biomarker was tested using a 0.100 margin of difference in sensitivity and specificity.
Among 53 analyzed patients (24 STEMI, 45.3%), the area under the receiver operating characteristic curve of qSTEMI and consensus score were 0.815 (0.691-0.938) and 0.736 (0.594-0.879), respectively (=0.081). Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of qSTEMI were 0.750 (0.583-0.917), 0.862 (0.690-0.966), 0.826 (0.679-0.955), and 0.813 (0.714-0.929), respectively. For the consensus score, sensitivity, specificity, PPV, and NPV were 0.708 (0.500-0.875), 0.793 (0.655-0.966), 0.750 (0.600-0.941), and 0.760 (0.655-0.880), respectively. The 95% confidence interval of sensitivity and specificity differences between qSTEMI and consensus score were 0.042 (-0.099-0.182) and 0.103 (-0.043-0.250), respectively, confirming qSTEMI's non-inferiority.
The digital STEMI biomarker, derived from printed prehospital ECGs, demonstrated non-inferiority to expert consensus, indicating a promising approach for enhancing prehospital telecardiology.
院前远程心脏病学有助于早期检测ST段抬高型心肌梗死(STEMI),但其广泛应用仍具有挑战性。使用手机摄像头从打印的心电图(ECG)中提取数字STEMI生物标志物可能提供一种经济实惠且可扩展的解决方案。本研究评估了这种方法在实际院前心电图中的可行性。
从一项政策研究数据集中识别出被紧急医疗技术人员(EMT)怀疑患有STEMI的患者。基于深度学习的心电图分析仪(QCG™分析仪)从院前心电图中提取STEMI生物标志物(qSTEMI)。将该生物标志物与一组专家进行比较,包括五位紧急医疗服务主任(获得董事会认证的急诊医师)和三位介入心脏病专家,根据他们的共识评分(对STEMI回答“是”的参与者数量)进行比较。使用灵敏度和特异性差异的0.100边际检验生物标志物的非劣效性。
在53例分析患者中(24例STEMI,占45.3%),qSTEMI的受试者操作特征曲线下面积和共识评分分别为0.815(0.691 - 0.938)和0.736(0.594 - 0.879)(=0.081)。qSTEMI的灵敏度、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为0.750(0.583 - 0.917)、0.862(0.690 - 0.966)、0.826(0.679 - 0.955)和0.813(0.714 - 0.929)。对于共识评分,灵敏度、特异性、PPV和NPV分别为0.708(0.500 - 0.875)、0.793(0.655 - 0.966)、0.750(0.600 - 0.941)和0.760(0.655 - 0.880)。qSTEMI与共识评分之间灵敏度和特异性差异的95%置信区间分别为0.042(-0.099 - 0.182)和0.103(-0.043 - 0.250),证实了qSTEMI的非劣效性。
从打印的院前心电图中衍生出的数字STEMI生物标志物显示出不劣于专家共识,表明这是一种增强院前远程心脏病学的有前景的方法。